"Hepatitis C Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.
Descriptor ID |
D018937
|
MeSH Number(s) |
D12.776.124.486.485.114.254.450.510 D12.776.124.790.651.114.254.450.510 D12.776.377.715.548.114.254.450.510
|
Concept/Terms |
Hepatitis C Antibodies- Hepatitis C Antibodies
- Hepatitis C Virus Antibodies
- HCV Antibodies
- Anti-HCV Antibodies
- Anti HCV Antibodies
- Anti-Hepatitis C Virus Antibodies
- Anti Hepatitis C Virus Antibodies
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C Antibodies".
This graph shows the total number of publications written about "Hepatitis C Antibodies" by people in this website by year, and whether "Hepatitis C Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 1 | 1 | 2 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis C Antibodies" by people in Profiles.
-
Coppock D, Chou E, Gracely E, Gross R, Heun-Lee D. Hepatitis C antibody screening and determinants of initial and duplicate screening in the baby boomer patients of six urban primary care clinics. PLoS One. 2020; 15(7):e0235778.
-
Pothineni NV, Rochlani Y, Vallurupalli S, Kovelamudi S, Ahmed Z, Hakeem A, Mehta JL. Comparison of Angiographic Burden of Coronary Artery Disease in Patients With Versus Without Hepatitis C Infection. Am J Cardiol. 2015 Oct 01; 116(7):1041-4.
-
Kohli A, Funk E, Burbelo P, Barrett L, Meissner EG, Santich B, Shaffer A, Johl J, Sidharthan S, Moir S, Kottilil S, Fauci AS. Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse. J Med Virol. 2015 Apr; 87(4):544-52.
-
Yehia BR, Herati RS, Fleishman JA, Gallant JE, Agwu AL, Berry SA, Korthuis PT, Moore RD, Metlay JP, Gebo KA. Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts. PLoS One. 2014; 9(7):e102766.
-
Santos C, Herrine SK. Making the best of a bad situation: early chronic nosocomial HCV infection. Dig Dis Sci. 2010 Jun; 55(6):1509-11.
-
Semmo N, Lucas M, Krashias G, Lauer G, Chapel H, Klenerman P. Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy. Blood. 2006 Jun 01; 107(11):4570-1.
-
Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N, Klenerman P. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet. 2005 Jan 22-28; 365(9456):327-9.
-
Herrine SK, Michael B, Ma WL, Rossi S, Dunn SR, Hyslop T. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis. Am J Gastroenterol. 2002 Oct; 97(10):2619-22.
-
Mandal AK, Kraus ES, Samaniego M, Rai R, Humphreys SL, Ratner LE, Maley WR, Burdick JF. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors. Clin Transplant. 2000 Aug; 14(4 Pt 2):391-6.